Discover how maladaptive schemas make most New Year’s resolutions fail, and how to approach change at a deeper level.

Chief Executive Officer Patrick Kabambe says the termination of the shipping and ports concession agreement was taken in the best interest of Malawi’s long-term development. Kabambe said the ...

Outlook Therapeutics faces a pivotal FDA decision for Lytenava on December 31st, following two prior rejections. Read why ...